Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zanchetti

Showing results (101-110 of 197) with videos related to

Pageof 20
Sort By:
Journal of Hypertension|March 27, 2003
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?Alberto Zanchetti, Lennart Hansson, Denis Clement, et al.
Journal of Hypertension|April 10, 2009
Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension?Meilikemu Masaidi, Cesare Cuspidi, Valentina Giudici, et al.
Journal of Hypertension|May 29, 2004
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, M Gene Bond, Michael Hennig, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|April 3, 2002
The risk functions incorporated in Riscard 2002: a software for the prediction of cardiovascular risk in the general population based on Italian dataAlessandro Menotti, Mariapaola Lanti, Paolo Emilio Puddu, et al.
Archives of Internal Medicine|March 26, 2008
Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rateMassimo Cirillo, Maria Paola Lanti, Alessandro Menotti, et al.
Journal of Hypertension|April 28, 2015
Antihypertensive treatment is not a risk factor for major cardiovascular events in the Gubbio residential cohort studyMariapaola Lanti, Paolo E Puddu, Oscar Terradura Vagnarelli, et al.
Journal of Hypertension|April 13, 2004
Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressureCesare Cuspidi, Stefano Meani, Maurizio Salerno, et al.
Journal of Hypertension|September 14, 2004
Metabolic syndrome and target organ damage in untreated essential hypertensivesCesare Cuspidi, Stefano Meani, Veronica Fusi, et al.
Journal of the American College of Cardiology|September 15, 2004
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE)Vasilios Papademetriou, Csaba Farsang, Dag Elmfeldt, et al.
Blood Pressure|December 8, 2004
Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome?Cesare Cuspidi, Stefano Meani, Veronica Fusi, et al.
Pageof 20

Showing results (101-110 of 197) with videos related to

Sort By:
Pageof 20
Journal of Hypertension|March 27, 2003
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?Alberto Zanchetti, Lennart Hansson, Denis Clement, et al.
Journal of Hypertension|April 10, 2009
Is retinal arteriolar-venular ratio associated with cardiac and extracardiac organ damage in essential hypertension?Meilikemu Masaidi, Cesare Cuspidi, Valentina Giudici, et al.
Journal of Hypertension|May 29, 2004
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, M Gene Bond, Michael Hennig, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|April 3, 2002
The risk functions incorporated in Riscard 2002: a software for the prediction of cardiovascular risk in the general population based on Italian dataAlessandro Menotti, Mariapaola Lanti, Paolo Emilio Puddu, et al.
Archives of Internal Medicine|March 26, 2008
Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rateMassimo Cirillo, Maria Paola Lanti, Alessandro Menotti, et al.
Journal of Hypertension|April 28, 2015
Antihypertensive treatment is not a risk factor for major cardiovascular events in the Gubbio residential cohort studyMariapaola Lanti, Paolo E Puddu, Oscar Terradura Vagnarelli, et al.
Journal of Hypertension|April 13, 2004
Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressureCesare Cuspidi, Stefano Meani, Maurizio Salerno, et al.
Journal of Hypertension|September 14, 2004
Metabolic syndrome and target organ damage in untreated essential hypertensivesCesare Cuspidi, Stefano Meani, Veronica Fusi, et al.
Journal of the American College of Cardiology|September 15, 2004
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE)Vasilios Papademetriou, Csaba Farsang, Dag Elmfeldt, et al.
Blood Pressure|December 8, 2004
Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome?Cesare Cuspidi, Stefano Meani, Veronica Fusi, et al.
Pageof 20